SeaDragon confirms full-year loss will widen

SeaDragon, which manufactures fish oils for health supplements, confirmed its 2017 annual loss would widen, in line with its previous guidance.

The Nelson-based fish oil refiner said its management and auditors are currently working through the year-end audit process, and it expects to report a loss of $4.3 million to $4.5 million on a normalised earnings before interest, tax, depreciation and amortisation basis, versus a 2016 loss of $400,000. That's in line with its previous guidance released March 1.

The earnings for the year ended March 31 will be released on of before May 31, the company said.

SeaDragon has previously attributed the loss to the length of time it has taken to transition from its legacy Omega-2 business to Omega-3 fish oil produced by its new refinery.

The shares were unchanged at 0.6 cents and have fallen 50 percent over the past year.

(BusinessDesk)

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Devon Funds Morning Note - 14 October 2026
BIT - Transaction in Own Shares
PHL - Operational Update - Q2 FY27
October 14th Morning Report
MCY - Employee Share Scheme - Financial Assistance Notice
PGW - PGG Wrightson FY27 Market Guidance
TEM - Transaction in Own Shares
October 13th Morning Report
October 12th Morning Report
TEM - Transaction in Own Shares